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Abstract
The utilization of a monomer-on-monomer (MoM) intramolecular Mitsunobu cyclization reaction
employing norbornenyl-tagged (Nb-tagged) reagents is reported for the synthesis of benzofused
thiadiazepine-dioxides. Facile purification was achieved via ring-opening metathesis (ROM)
polymerization initiated by one of three metathesis catalyst methods: (i) free metathesis catalyst,
(ii) surface-initiated catalyst-armed silica, or (iii) surface-initiated catalyst-armed Co/C magnetic
nanoparticles.
The ongoing effort in the search for new pharmacophores and small molecular probes is a
key feature of modern drug discovery. The Mitsunobu reaction and its variants1 represent
versatile synthetic methods which are pivotal to accessing small molecules for drug
discovery.2 The Mitsunobu reaction is a mild and effective method for the conversion of
alcohols into a variety of functionality through the formation of C–C, C–O, C–N and C–S
bonds, including the ability to invert the stereochemistry of stereogenic carbinol-bearing
centers. A formal “redox” reaction, the Mitsunobu reaction is promoted under relatively
mild conditions by a combination of a tertiary phosphine, usually triphenylphosphine (PPh3)
and an azodicarboxylate, usually diethyl or diisopropyl ester (DEAD or DIAD). Such is the
scope of the Mitsunobu reaction, its application has played a pivotal role in the synthesis of
natural products,3 and bioactive small molecules.4 Despite these powerful attributes, the
Mitsunobu reaction suffers from the need for tedious purifications to isolate the desired
product, an operational disadvantage in both high-throughput chemistry and natural prodcut
synthesis. Addressing this issue, several variants of the Mitsunobu reaction have been
developed which include tagged, immobilized and water-soluble reagents that allow for
facile separation of the desired product from unwanted Mitsunobu by-products.5
Methods developed within our group for facile purification-free Mitsunobu protocols have
focused on the application of a polymer-on-polymer (PoP) Mitsunobu protocol, employing
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ROMP-derived oligomeric triphenylphosphine (OTPP) and oligomeric benzylethyl
azodicarboxylate (OBEAD) reagents,6 as well as a monomer-on-monomer
(MoM)Mitsunobu protocol, employing norborneneyl-tagged (Nb-tagged) PPh3 and BEAD
reagents.7 In the latter case, facile sequestration of the excess and spent reagents was
achieved via ring-opening metathesis (ROM) polymerization initiated by any one of three
methods utilizing Grubbs catalyst [(IMesH2)(PCy3)(Cl)2Ru=CHPh cat-B]:8 (i) free catalyst
in solution, (ii) surface-initiated catalyst-armed silica,9,10 or (iii) surface-initiated catalyst-
armed carbon-coated (Co/C) magnetic nanoparticles (Nps) (Scheme 1).7,11
The intramolecular Mitsunobu reaction has been widely utilized as a cyclization protocol for
the synthesis of heterocyclic molecules.12 Building on these reports, we herein report the
synthesis of benzofused thiadiazepine-dioxides via an intramolecular 7-membered MoM
Mitsunobu cyclization reaction, whereby facile purification was achieved utilizing ROMP
sequestration initiated by free metathesis catalyst or catalyst-armed particle surfaces
(Scheme 2).
The synthesis of benzofused thiadiazepine-dioxides 3a and 3b was investigated utilizing the
intramolecular MoM Mitsunobu cyclization with the readily prepared Nb-tagged PPh3 (Nb-
TPP) and DEAD (Nb-BEAD) reagents.6 The corresponding hydroxy-benzylsulfonamide
starting materials 2a and 2b were rapidly generated via a microwave-assisted SNAr protocol
(Scheme 3).13
With sulfonamides 2a–b in hand, the application of MoM cyclization reaction was
investigated utilizing Nb-TPP and Nb-BEAD (Table 1). Initially, purification was achieved
by phase switching of all Nb-tagged species in solution (monomeric reagents and spent
reagents) by addition of free metathesis catalyst [(IMesH2)(PCy3)(Cl)2Ru=CHPh, cat-B]
(Method A) to induce ROM polymerization. The ROM polymerization event was followed
by precipitation to produce the desired benzofused thiadiazepine-dioxides 3a and 3b in good
yield and excellent crude purity (Table 1, entries 1–2). Purification was followed by TLC
analysis, whereby the typical Mitsunobu multispot crude reaction mixture was reduced to a
single spot after utilizing this polymerization sequestration protocol. Despite this success,
the need for precipitation of the crude reaction mixture to remove the polymerized reagents/
spent reagents was deemed not ideal for a high-throughput appproach. Therefore, alternative
syntheses of benzofused thiadiazepine-dioxides 3a and 3b were investigated utilizing a
catalyst-armed surface generated from either Nb-tagged Co/C magnetic particles, or Nb-
tagged silica particles.
After polymerization sequestration of excess reagents/spent reagents on the surface of the
magnetic Co/C beads [Method B], 3a and 3b could be obtained in reasonable crude purity
by collecting the nanobeads with an external magnet, decanting the solution and evaporating
the solvent (Table 1, entries 3–4). Noteworthy, this work-up procedure is carried out within
a few seconds, being an operational advantage to conventional filtration techniques.
However, to further improve the product purity the solution was filtered over a silica SPE.
As an alternative method, the sequestration by Nb-tagged silica particles [Method C] was
applied to generate 3a and 3b in comparable yields and purities with simple filtration
through Celite® SPE to isolate the desired product, avoiding the need for precipitation
(Table 1, entries 5–6). Building on these results, substrate scope was evaluated across all
three purification sequestration protocols A–C for the synthesis of 3c–3n via MoM
Mitsunobu cyclization (Scheme 4). Thus, benzofused thiadiazepine-dioxides 3c–3f were
generated with free cat-B [Method A], compounds 3g–3j via Nb-tagged Co/C magnetic
particles [Method B] and benzofused thiadiazepine-dioxides 3k–3n utilizing Nb-tagged
Silica particles [Method C].
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In conclusion, we have demonstrated the application of a MoM intramolecular Mitsunobu
cyclization for the synthesis of bi- and tri-cyclic benzofused thiadiazepine-dioxides. Facile
purification of crude reaction mixtures was achieved via ROM polymerization sequestration
of excess reagents/spent reagents. This was accomplished initially utilizing free metathesis
catalyst Cat-B, followed by precipitation. The method was further optimized utilizing
catalyst-armed surfaces generated from either Nb-tagged Si-particles or Nb-tagged Co/C
magnetic nano-particles.
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Catalyst-armed Silica- and Co/C magnetic nanoparticles.
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Synthesis of benzofused thiadiazepine-dioxides via a intramolecular MoM Mitsunobu c/
yclization.
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Synthesis of hydroxy-benzylsulfonamides 2a–b via microwave- assisted SNAr.
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Synthesis of benzofused thiadiazepine-dioxides. (3c–3f: Method A; 3g–3j: Method B; 3k–
3n: Method C).
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